Fengxiaquan (Shanghai) Technology Co., Ltd. was founded in April 2021, and its wholly-owned subsidiary, Anqing Jusha New Material Technology Co., Ltd., was established in May 2025. Fengxiaquan (Shanghai) Technology Co., Ltd. is an industry-trade integrated enterprise specializing in the research and development, technology transformation, and industrial scale-up production of functional materials, pharmaceutical and pesticide intermediates. Its products mainly cover the R&D, production and sales of new energy battery materials, electroluminescent organic materials, photosensitive materials, pharmaceutical intermediates, pesticide intermediates, as well as catalysts and extractants. Over the past five years.

The company has developed more than 100 independently researched and developed, uniquely featured products eligible for large-scale production, while actively expanding its international import and export business. Its total production and sales volume, as well as profits and taxes, are in a stage of explosive growth. At present, the company has established long-term and stable cooperative relations with many well-known enterprises at home and abroad. It has also set up joint development mechanisms with multiple national-level laboratories, including those affiliated with Peking University, Shanghai Jiao Tong University, Shanghai University, Shanghai Institute of Organic Chemistry, Nanjing University of Posts and Telecommunications, Northwestern Polytechnical University, and Guangzhou Institute of Chemistry, securing high-quality technological resources.

The general manager and legal representative of the company is Dr. Chen Qingquan, who graduated from Fudan University and studied under academician Huang Wei of the Chinese Academy of Sciences. At present, the company's R&D team has a total of 20 people, including 1 doctor degree, 2 graduate degrees, and 5 part-time experts to guide the R&D team, including 1 academician of the CAS Member, and 4 college professors. At present, the team members have at least 15 years of industry professional experience, and have accumulated over 60 projects that have successfully achieved pilot scale production (covering various chemicals in functional materials, synthetic drugs, and other fields). Over 20 projects have achieved ton level mass production, and the cumulative technology conversion output value has exceeded 500 million yuan. The company will transform laboratory trial technology into large-scale production in factories. Based on the principles of universal production equipment, safe and green processes, and the lowest comprehensive cost, the company will establish scaling rules for key processes such as synthesis, purification, and drying through process validation and optimization. The company will also scale up production and mass production validation at the production site, ultimately achieving the transformation of laboratory science and technology into actual productivity that meets market demand. In the next 5 years, the company will promote product updates year by year, with an annual sales value growth of no less than 30%, and profits and taxes will increase synchronously.